world
Novo, Lilly to take obesity battle to India
The Economic Times
September 30, 2026
via The Economic TimesYou're reading one story from Newsaly
Newsaly brings together 60,000+ newspaper articles, 30,000+ podcasts and 10,000+ magazine articles from around the world.
A World Of News, One Window.
Explore Today's News
Mumbai: India's obesity drug market is gearing up for its next big fight-this time over a pill, not a jab.Danish drugmaker Novo Nordisk's oral Wegovy (semaglutide) and US pharma major Eli Lilly's oral GLP-1 orforglipron are expected to enter India in the first half of 2027, according to industry sou
Read the full story
Explore More On Newsaly
Voices (0)
Share a 15-second voice reaction. Voices automatically disappear after 10 days.
Sign in to record a voice on this article.
Be the first to share a voice on this article.